landiolol has been researched along with Arrhythmia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, Y; Kawano, S; Mathis, BJ; Matsuishi, Y; Shimojo, N | 1 |
| Landoni, G; Monaco, F; Poveda-Jaramillo, R; Zangrillo, A | 1 |
| Kikawa, S; Taenaka, N | 1 |
| Kitano, M; Komasawa, N; Minami, T; Sawai, T | 1 |
| Adachi, YU; Ejima, T; Hatano, T; Matsuda, N; Numaguchi, A; Obata, Y; Sato, S; Suzuki, K | 1 |
| Fukutomi, T; Nishimori, H; Radhakrishnan, G; Sasaguri, S; Wariishi, S; Yamamoto, M; Yamashita, K | 1 |
| Doi, M; Fukuta, S; Kobayashi, S; Matsuzaki, M; Murakami, W; Nao, T; Okamura, T; Okuda, S; Susa, T; Tanaka, T; Wada, Y; Yamada, J; Yano, M | 1 |
| Yasumura, Y | 1 |
| Minami, K; Ogata, J; Okamoto, T; Yokoyama, T | 1 |
| Kanki, H; Mitamura, H; Ogawa, S; Sueyoshi, K; Takatsuki, S | 1 |
2 review(s) available for landiolol and Arrhythmia
| Article | Year |
|---|---|
Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care; Female; Heart Rate; Humans; Male; Morpholines; Risk Factors; Treatment Outcome; Urea; Young Adult | 2020 |
Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Critical Illness; Heart Rate; Humans; Morpholines; Myocardial Ischemia; Perioperative Period; Propanolamines; Urea | 2018 |
1 trial(s) available for landiolol and Arrhythmia
| Article | Year |
|---|---|
Continuous administration of landiolol reduced QT dispersion in postoperative patients.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Postoperative Care; Postoperative Complications; Prospective Studies; Urea | 2014 |
8 other study(ies) available for landiolol and Arrhythmia
| Article | Year |
|---|---|
Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Female; History, 17th Century; Humans; Male; Morpholines; Postoperative Period; Prospective Studies; Receptors, Adrenergic, beta-1; Urea | 2013 |
[Successful anesthetic management of a patient with giant pheochromocytoma using high-dose landiolol hydrochloride].
Topics: Adrenal Gland Neoplasms; Analgesia, Epidural; Anesthesia, General; Arrhythmias, Cardiac; Catecholamines; Contraindications; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Injections, Intravenous; Intraoperative Complications; Male; Middle Aged; Morpholines; Phentolamine; Pheochromocytoma; Urea | 2014 |
Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atrial Premature Complexes; Blood Pressure; Drug Administration Schedule; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Postoperative Care; Surgical Procedures, Operative; Tachycardia, Sinus; Time Factors; Treatment Outcome; Urea | 2009 |
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Chi-Square Distribution; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Japan; Male; Middle Aged; Milrinone; Morpholines; Prospective Studies; Pulmonary Wedge Pressure; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Urea; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Combination of β-blocker and milrinone for acute heart failure.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Male; Milrinone; Morpholines; Urea; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Managing a tachyarrhythmia in a patient with pheochromocytoma with landiolol, a novel ultrashort-acting beta-adrenergic blocker.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Anesthesia; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Intraoperative Complications; Middle Aged; Morpholines; Pheochromocytoma; Urea | 2003 |
Landiolol. ONO 1011.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drugs, Investigational; Guinea Pigs; Humans; In Vitro Techniques; Morpholines; Urea | 1999 |
Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Drug Therapy, Combination; Electrocardiography; Female; Heart; Heart Ventricles; Male; Morpholines; Myocardial Infarction; Piperidines; Potassium Channel Blockers; Pyridines; Urea | 2000 |